FFAR2 and Impaired glucose tolerance: Mice lacking GPR41 and GPR43 showed a reduction in SCFAs-induced glucagon-like peptide (GLP-1) release, impaired glucose tolerance [48] as well as increased inflammation in white adipose [49].